
How foreign aid cuts are setting the stage for disease outbreaks
Advertisement
'Diseases make their way to the United States even when we have our best people on it, and now we are not putting our best people on it,' he added.
In interviews, more than 30 current and former officials of the US Agency for International Development, members of health organizations and experts in infectious diseases described a world made more perilous than it was just a few weeks ago.
Many spoke on condition of anonymity for fear of retaliation by the federal government.
The timing is dire: Congo is experiencing the deadliest mpox outbreak in history, with cases exploding in a dozen other African countries.
The United States is home to a worsening bird flu crisis. Multiple hemorrhagic fever viruses are smoldering: Ebola in Uganda, Marburg in Tanzania, and Lassa in Nigeria and Sierra Leone.
In 2023, USAID invested about $900 million to fund labs and emergency-response preparedness in more than 30 countries. The pause on foreign aid froze those programs. Even payments to grantees for work already completed are being sorted out in the courts.
Waivers issued by the State Department were intended to allow some work to continue on containing Ebola, Marburg, and mpox, as well as preparedness for bird flu.
But Trump administration appointees choked payment systems and created obstacles to implementing the waivers, according to a USAID memo by Nicholas Enrich, who was the agency's acting assistant administrator for global health until Sunday.
Advertisement
Then last month, the Trump administration canceled about 5,800 contracts, effectively shuttering most USAID-funded initiatives, including many that had received permission to continue.
'It was finally clear that we were not going to be implementing' even programs that had waivers, Enrich recalled in an interview.
The decision is likely to result in more than 28,000 new cases of infectious diseases such as Ebola and Marburg, and 200,000 cases of paralytic polio each year, according to one estimate.
Secretary of State Marco Rubio 'has been working diligently since being sworn in to review every dollar spent,' the State Department said in an emailed statement.
'We'll be able to say that every program that we are out there operating serves the national interest, because it makes us safer or stronger or more prosperous,'' the statement quoted Rubio as saying.
Most USAID staff members were terminated or placed on administrative leave without warning. The agency had more than 50 people dedicated to outbreak responses, the result of a congressional push to beef up pandemic preparedness.
Now it has six. Those who were fired included the organization's leading expert in lab diagnostics and the manager of the Ebola response. 'I have no idea how six people are going to run four outbreak responses,' said an official who was let go.
Also sent home were hundreds of thousands of community health workers in Africa who were sentinels for diseases.
In early January, the Tanzanian government denied there were new cases of Marburg, a hemorrhagic fever. It was a community health worker trained through a US-funded Ebola program who reported the disease a week later.
Advertisement
The outbreak eventually grew to include 10 cases; it is now under control, the government has said.
Even in quieter times, foreign aid helps to prevent, detect and treat diseases that can endanger Americans, including drug-resistant HIV, tuberculosis and malaria, and bacteria that don't respond to available antibiotics.
Much of that work has stopped, and other organizations or countries cannot fill the gap. Compounding the loss is America's withdrawal from the World Health Organization, which has instituted cost-cutting measures of its own.
'This is a lose-lose scenario,' said Dr. Keiji Fukuda, who has led pandemic prevention efforts at the WHO and the Centers for Disease Control and Prevention.
The slashing of foreign aid deprives the world of American leadership and expertise, but it also locks the United States out of global discussions, Fukuda said: 'For the life of me, I cannot see the justification or the reason for this very calculated, systematic approach to pull down public health.'
Some African countries such as Somalia have fragile health systems and persistent security threats, yet minimal capacity for tracking infections that sicken animals and people, said Abdinasir Yusuf Osman, a veterinary epidemiologist and chair of a working group in Somalia's health ministry.
Each year, Somalia exports millions of camels, cattle, and other livestock, primarily to the Middle East. The nation has relied heavily on foreign aid to screen the animals for diseases, he said.
'The consequences of this funding shortfall, in my view, will be catastrophic and increase the likelihood of uncontrolled outbreaks,' Osman said.
Advertisement
In countries with larger economies, foreign aid has helped build relationships. Thailand is a pioneer in infectious diseases, and USAID was funding a modest project on malaria elimination that boosts its surveillance capabilities.
The abrupt end to that commitment risks losing goodwill, said Jui Shah, who helped run the program.
'In Asia, relationships are crucial for any type of work, but especially for roles that work with surveillance and patient data,' she said. 'Americans will suffer if other countries hesitate to engage with us about outbreaks.'
This article originally appeared in
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Boston Globe
11 minutes ago
- Boston Globe
How hurricanes, fires, and floods put drugs and medical supplies at risk
Advertisement These threats are especially pressing as the Trump administration makes a push to ramp up US drug manufacturing, say the authors of the new research. As part of a broader effort to increase US pharmaceutical factories, President Donald Trump has threatened to impose tariffs on imported medicines, a move that could make the country more reliant on domestically produced supplies. Roughly 40% of finished medications and 80% of active pharmaceutical ingredient components come from abroad, according to US Food and Drug Administration estimates. Get Starting Point A guide through the most important stories of the morning, delivered Monday through Friday. Enter Email Sign Up 'Climate change-driven extreme weather events impose new threats to established vulnerabilities in the US drug supply,' the study's authors wrote. 'Those threats must be examined to be appropriately mitigated.' The analysis used FDA and Federal Emergency Management Agency databases to find drug production facilities in counties with major fire, hurricane, storm, tornado and flood events between 2019 and 2024. California, Florida and North Carolina were home to the largest numbers of facilities in counties with presidential disaster declarations. Advertisement Hurricanes were the most common of the climate-related disasters in areas with pharmaceutical facilities, according to the research. In 2017, Hurricane Maria hit Puerto Rico and disrupted Baxter's saline solution manufacturing facility there. Baxter is a major manufacturer of the sterile salt water widely used in hospitals to deliver medications and keep patients hydrated. The company didn't have backup facilities manufacturing smaller bags of the saline solution, which compounded pre-existing supply issues. Baxter has said it's learned from Maria and now has a more resilient supply chain, citing manufacturing investments and FDA clearance to produce saline outside of the US if needed. Even resilient supply chains are prone to climate shocks, though. Helene flooded Baxter's North Carolina facility, which made 60% of the IV fluid bags used in US hospitals for various functions, including to deliver medicine. Baxter reported earlier this year that the North Carolina plant was back at pre-hurricane production levels, and the FDA said this month that the shortages had resolved. Sarah Ryan, a spokesperson for pharmaceutical industry group PhRMA, says that the industry works with government regulators to avoid shortages. The new research did not determine how often such disasters result in shortages, saying that data wasn't readily available. ©2025 Bloomberg L.P.


Axios
41 minutes ago
- Axios
HHS workers accuse RFK Jr. of stoking violence against them
More than 750 current and former federal health workers on Wednesday accused HHS Secretary Robert F. Kennedy Jr. of contributing to harassment and violence against government employees they said manifested itself in the Aug. 8 attack on CDC's Atlanta headquarters. Why it matters: The workers, in a letter to Kennedy and members of Congress, called on Kennedy to publicly disavow and stop spreading inaccurate and misleading claims about vaccines, disease transmission and public health institutions. They're also asking him to affirm CDC's non-partisan and scientific integrity. HHS should improve emergency procedures and alerts, and take "vigorous action" to remove material online that targets federal workers, including "DEI watchlists," the letter states. The letter asks for a response from Kennedy by Sept. 2. What they're saying: The letter charges Kennedy as being " complicit in dismantling America's public health infrastructure and endangering the nation's health by repeatedly spreading inaccurate health information." Actions like ousting members of a CDC vaccine advisory board, questioning the safety of measles vaccine and terminating critical CDC workers "have contributed to the harassment and violence experienced by CDC staff," the workers wrote. "The deliberate destruction of trust in America's public health workforce puts lives at risk. We urge you to act in the best interest of the American people—your friends, your families, and yourselves," the letter states.


Medscape
41 minutes ago
- Medscape
Before You Commit to Fellowship, Consider This
This transcript has been edited for clarity. Are you thinking about doing a fellowship? Here are five key questions to ask yourself. First, do you genuinely love the subspecialty or are you feeling pressured to keep going because everyone else is? Second, does the fellowship align with your long-term career goals, whether that's academic medicine, private practice, or a niche clinical role? Third, will it significantly impact your lifestyle or your income? Is that a tradeoff that's worth it to you? Fourth, are you ready to commit to more years of training, or are you already feeling burned out and ready to be done? Finally, have you explored all your options within general practice?Sometimes you can tailor your career without additional training. A fellowship can be incredibly rewarding, but it should be a strategic choice and not just the default next step.